Arix Bioscience

Arix Bioscience, a UK-based research and development services company, reported total Scope 1, 2, and 3 emissions of approximately 13,300 kg CO2e in 2022. This includes about 3,680 kg CO2e from Scope 1 emissions, 4,410 kg CO2e from Scope 2 (market-based), and 5,210 kg CO2e from Scope 3 emissions.

For 2021, the company's total emissions were approximately 15,370 kg CO2e, comprising around 4,860 kg CO2e in Scope 1, 7,800 kg CO2e in Scope 2 (market-based), and 2,900 kg CO2e in Scope 3.

In 2020, Arix Bioscience's reported Scope 1 and Scope 2 emissions (market-based) were approximately 5,020 kg CO2e and 5,110 kg CO2e, respectively. For 2019, the total reported emissions were approximately 17,100 kg CO2e, with Scope 1 at about 11,500 kg CO2e and Scope 2 (market-based) at around 5,600 kg CO2e.

Arix Bioscience has set a long-term net-zero target to reduce more than 90% of its all-scope emissions by 2050 or sooner. Additionally, the company aims for a 40% reduction in carbon emissions by 2025 against a 2019 baseline, normalised to occupied areas.